文献速递细胞病理与分子病理神经与头颈病理

高危HPV原位杂交在囊性头颈部病变细胞块中的应用

The utility of high-risk human papillomavirus in situ hybridization in cytology cell block material from cystic head and neck lesions.
PubMed 文献 · Cancer Cytopathol · 2021-11-10

本研究评估了细胞块高危HPV原位杂交(C-hrHPV ISH)在囊性颈部病变细针穿刺(FNA)中的效用,并与p16免疫组化(C-p16)及手术标本HPV ISH(S-hrHPV ISH)对比。结论认为C-hrHPV ISH阳性可靠,阴性或不确定需重复检测,较C-p16更具诊断价值。

要点

  • C-hrHPV ISH阳性结果可靠,12例均与手术标本一致,无假阳性。
  • C-hrHPV ISH阴性或不确定时可能需重复检测,因存在与手术不一致的情况。

核心结论

  • C-hrHPV ISH可可靠用于囊性颈部病变细胞块,尤其阳性结果可靠。
  • C-hrHPV ISH阴性或不确定解读可能需重复检测。
  • 与C-p16相比,C-hrHPV ISH更常具有诊断性,有助于HPV-OPSCC诊断和管理。

研究设计与样本

  • 细胞块行p16 IHC(C-p16)和hrHPV ISH(C-hrHPV ISH),手术标本行hrHPV ISH(S-hrHPV ISH)。
  • 结果分类为阴性、阳性或不确定;2例因组织不足排除。

主要发现

  • C-hrHPV ISH阳性12例,均与S-hrHPV ISH一致,无假阳性。
  • C-hrHPV ISH阴性5例中4例与S-hrHPV ISH一致,1例不一致。
  • C-hrHPV ISH不确定5例,S-hrHPV ISH结果有阳有阴。

临床怎么用

  • 对囊性颈部病变细胞块可优先采用C-hrHPV ISH辅助诊断HPV-OPSCC。
  • C-hrHPV ISH阳性结果可支持HPV相关诊断。
  • C-hrHPV ISH阴性或不确定时,建议重复检测或结合手术标本验证。

局限性

  • 部分病例C-hrHPV ISH结果不确定,判读存在挑战。
  • 为单中心回顾性研究,需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human papillomavirus-related oropharyngeal squamous cell carcinoma (HPV-OPSCC) presents frequently as metastasis in a neck lymph node that may be cystic or necrotic. Fine-needle aspiration (FNA) biopsies are often first-line diagnostic procedures. p16 immunohistochemistry (IHC) is a surrogate marker for high-risk HPV (hrHPV) infection but can be challenging to interpret. This study evaluated the use of hrHPV in situ hybridization (ISH) in cytology cell blocks of cystic neck lesions. METHODS: Twenty-four FNA cases with cell blocks and surgical correlates were evaluated. p16 IHC and hrHPV ISH were assessed on cell blocks (C-p16 and C-hrHPV ISH), and hrHPV ISH on surgical samples (S-hrHPV ISH). All results were classified as negative, positive, or equivocal. RESULTS: Two cases were excluded because of insufficient tissue on recut. On the basis of C-hrHPV ISH cases, 12 were positive, 5 were negative, and 5 were equivocal. All 12 positive C-hrHPV ISH cases had concordant S-hrHPV ISH with no false positives. Of the 5 negative C-hrHPV ISH cases, 4 had concordant S-hrHPV ISH, and 1 had a discordant S-hrHPV ISH. Of the 5 equivocal C-hrHPV ISH cases, S-hrHPV ISH were both positive and negative. Fourteen cases were equivocal by C-p16; 9 cases were reliably classified by C-hrHPV ISH (5 positive, 4 negative; 64%). CONCLUSIONS: C-hrHPV ISH can be reliably used, especially when positive. A negative or equivocal interpretation of C-hrHPV ISH may warrant repeat testing. Compared to C-p16, C-hrHPV ISH is more frequently diagnostic and could be helpful for HPV-OSCC diagnosis and management.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Han LM, Saunders TA, Calkins SM, et al. The utility of high-risk human papillomavirus in situ hybridization in cytology cell block material from cystic head and neck lesions. Cancer Cytopathol. 2021. PMID: 34758205. doi:10.1002/cncy.22529

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。